ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,804
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
Author(s):
P.M. George
,
A.U. Wells
,
R.G. Jenkins
Publication date:
2022
Journal:
Lancet Respir. Med.
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Bristol University Press: COVID-19
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
2,804
Antifibrotic Actions of Peroxisome Proliferator-Activated Receptor γ Ligands in Corneal Fibroblasts Are Mediated by β-Catenin–Regulated Pathways
Authors:
Kye-Im Jeon
,
Krystel R. Huxlin
,
Richard P. Phipps
…
Antifibrotic effect by activation of peroxisome proliferator-activated receptor–γ in corneal fibroblasts
Authors:
Hongwei Pan
,
Jiansu Chen
,
Jintang Xu
…
HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
Authors:
Xing Lyu
,
Min Hu
,
Jieting Peng
…
See all similar
Cited by
1
Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis
Authors:
Meng-Chuan Wang
See all cited by